SILVERMAN, G. J., & PELZEK, A. (2014). Rheumatoid Arthritis Clinical Benefits from Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses. J Rheumatol.
Chicago-стиль цитированияSILVERMAN, GREGG J., and ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
MLA-цитированиеSILVERMAN, GREGG J., and ADAM PELZEK. "Rheumatoid Arthritis Clinical Benefits From Abatacept, Cytokine Blockers, and Rituximab Are All Linked to Modulation of Memory B Cell Responses." J Rheumatol 2014.
Предупреждение: эти цитированмия не могут быть всегда правильны на 100%.